A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
מצבים רפואיים
Unresectable Melanoma · Metastatic Melanoma · Stage III Non-small Cell Lung Cancer · Stage IV Non-small Cell Lung Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
The Angeles Clinic and Research Institute, Los Angeles, California, United States
Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Orlando Health Cancer Institute, Orlando, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
The University of Kansas Cancer Center, Westwood, Kansas, United States
University of Louisville, Louisville, Kentucky, United States
Weill Medical College of Cornell University, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of Cincinnati, Cincinnati, Ohio, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
מובילי המחקר
Iovance Biotherapeutics Study Team
Study Director
Iovance Biotherapeutics